Publications by authors named "Luis Ortega-Paz"

Claim this Profile
C
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
Mattia Galli, Stefano Benenati, Claudio Laudani, Beatrice Simeone, Gianmarco Sarto, Luis Ortega-Paz

J Am Coll Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials.
Luis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, Sina Rashedi, Jean M Connors

Thromb Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of oral antiplatelet strategies for patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Claudio Laudani, Luis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo

Expert Opin Drug Saf· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and optimal use of direct oral anticoagulant therapy.
Claudio Laudani, Luis Ortega-Paz, Ali Zgheib, Georges El Khoury, Mohmmad Alawajneh

Expert Opin Drug Saf· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Body Mass Index on 10-Year Outcomes in Patients Treated with Percutaneous Coronary Intervention and Drug-Eluting Stents (the DECADE Cooperation).
Maria Scalamogna, Fiorenzo Simonetti, J J Coughlan, Luis Ortega-Paz, Lorenz Räber

Eur J Prev Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of patient's weight and body mass index on presentation, time of onset, and impact of postoperative venous thromboembolism (RIETE registry).
Julio Santoyo Villalba, Juan Ignacio Arcelus, Manuela Expósito-Ruiz, Ana Martínez de Mandojana, Silvia Soler Simon, Luis Ortega-Paz

J Thromb Thrombolysis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions.
Sina Rashedi, Hannah Leyva, Nada Hamade, Mariana B Pfeferman, Luis Ortega-Paz

J Am Coll Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled Studies.
Luis Ortega-Paz, Yasushi Ueki, Claudio Laudani, Sylvain Losdat, Francesco Franchi

Thromb Haemost· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocardial infarction induces endothelial dysfunction with independence of cardiovascular risk factors.
Francisco Rafael Jimenez-Trinidad, Núria Solanes, Marta Arrieta, Blanca Llonch, Mercè Roqué, Luis Ortega-Paz

Angiogenesis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplatelet therapy following conservatively managed spontaneous coronary artery dissection.
Madeline K Mahowald, Luis Ortega-Paz, Claudio Laudani, Dominick J Angiolillo

J Thromb Thrombolysis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin or P2Y Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes.
Claudio Laudani, Daniele Giacoppo, Giovanni Occhipinti, Mattia Galli, Antonio Greco, Luis Ortega-Paz

JACC Cardiovasc Interv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary Intervention.
Claudio Laudani, Daniele Giacoppo, Antonio Greco, Luis Ortega-Paz, Georges El Khoury

J Clin Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants.
Luis Ortega-Paz, Cameron D Thomas, Claudio Laudani, Salvatore Giordano, Francesco Franchi

Clin Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenic effect of circulating extracellular vesicles in acute coronary syndrome: Role of miR-199a-3p and miR-125a-5p.
Joaquin Bobi, Francisco-Rafael Jimenez-Trinidad, Luis Ortega-Paz, Nuria Cortes-Serra, Iolanda Lazaro

Eur J Clin Invest· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnesium-Based Resorbable Scaffold vs Sirolimus-Eluting Stent in STEMI Patients: 5-Year Results of the MAGSTEMI Trial.
Manel Sabaté, Fernando Alfonso, Josep Gómez-Lara, Sebastián Romaní, Pascual Bordes, Luis Ortega-Paz

JACC Cardiovasc Interv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Phenotype, P2Y Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy.
Rajiv C Patel, Cameron D Thomas, Joseph S Rossi, Francesco Franchi, Ellen C Keeley, Luis Ortega-Paz

J Am Heart Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis.
Giovanni Occhipinti, Claudio Laudani, Mattia Galli, Luis Ortega-Paz, Vijay Kunadian

Eur Heart J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction-DAPA-STEMI Trial.
Luis Ortega-Paz, Claudio Laudani, Alessandro Sionis, Pablo Vidal-Cales, Victor Arevalos

J Cardiovasc Dev Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet Function Profiles in Patients With Ischemia and Nonobstructed Coronary Arteries.
Riccardo Rinaldi, Giovanni Occhipinti, Luis Ortega-Paz, Anthony Salazar, Ana Paula Dantas

JACC Cardiovasc Interv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which patients need thromboprophylaxis for venous thromboembolism prevention after hospitalization due to COVID-19? A sub-analysis from the CV COVID-19 registry.
Andrea Ruberti, Luis Ortega-Paz, Salvatore Brugaletta,

Med Clin (Barc)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking Status at Baseline and 10-Year Outcomes After Drug-Eluting Stent Implantation: Insights From the DECADE Cooperation.
Antonia Presch, J J Coughlan, Sarah Bär, Salvatore Brugaletta, Michael Maeng, Luis Ortega-Paz

JACC Cardiovasc Interv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from cangrelor to oral P2Y inhibitors: a focused review on drug-drug interactions.
Giovanni Occhipinti, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Davide Capodanno

Expert Opin Drug Metab Toxicol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[[Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trial]].
Pablo Vidal-Calés, Kamil Bujak, Riccardo Rinaldi, Anthony Salazar-Rodríguez, Luis Ortega-Paz

REC Interv Cardiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study).
Dhanunjaya Lakkireddy, Dominick J Angiolillo, Kristofer Charlton-Ouw, Brian Jefferson, Syed Peeran, Luis Ortega-Paz

Clin Cardiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching Platelet P2Y Receptor Inhibiting Therapies.
Luis Ortega-Paz, Fabiana Rollini, Francesco Franchi, Dirk Sibbing, Dominick J Angiolillo

Interv Cardiol Clin· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis